Status:
UNKNOWN
Early Palliative Care for Patients With Haematological Malignancies
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Fondation Apicil
Association des foulées de la Haute Lozère
Conditions:
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Eligibility:
All Genders
70+ years
Phase:
PHASE3
Brief Summary
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncolo...
Detailed Description
Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncolo...
Eligibility Criteria
Inclusion
- Patients are over 70 years old
- Patients from being diagnosed with acute myeloid leukemia and high-risk myelodysplastic syndrome or after the third line of therapy for high-grade lymphoma.
Exclusion
- All patients with a curative project (induction chemotherapy ou allogenic transplantation)
- All patients in a terminal palliative status
- Patients who don't speak French,
- Patients not able to read and write
- Patients who don't agree to participate in the protocol
- Patients with psychiatric troubles or cognitive disorders
- Patients under guardianship or curatorship, deprived of freedom or under justice protection.
Key Trial Info
Start Date :
March 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03800095
Start Date
March 14 2019
End Date
December 31 2023
Last Update
March 24 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Métropole Savoie
Chambéry, France, 73000
2
Chu Clermont-Ferrand
Clermont-Ferrand, France, 63003
3
Chu Limoges
Limoges, France, 87042
4
Centre Léon Bérard
Lyon, France, 69008